FIELD: cardiology. SUBSTANCE: in patient, ultralow-frequency indexes of spectral analysis of cardiac rhythm variability are measured. In dependence of values obtained, beta-blockers, calcium antagonists, inhibitors of angiotensin-converting enzymes or their combination are administered. EFFECT: increased accuracy and accelerated selection of preparations. 6 tbl, 3 ex
Authors
Dates
2000-01-27—Published
1998-11-05—Filed